B

BeyondSpring
D

BYSI

1.75000
USD
0.03
(1.74%)
مغلق
حجم التداول
5
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
70,525,613
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AGEN
    -0.11500
    (-3.34%)
    3.33000 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    C
    CRBP
    -0.09000
    (-1.09%)
    8.20000 USD
    C
    CYTK
    -0.820
    (-1.61%)
    50.260 USD
    K
    KURA
    0.11500
    (1.41%)
    8.26500 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    R
    RCKT
    -0.390
    (-3.59%)
    10.470 USD
    S
    SGMO
    -0.04500
    (-4.00%)
    1.08000 USD
    X
    XNCR
    -0.030
    (-0.19%)
    15.740 USD
    المزيد
الأخبار
المقالات

العنوان: BeyondSpring

القطاع: Healthcare
الصناعة: Biotechnology
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.